| Ticker Details |
Quanterix Corporation
Quanterix Corp is a life science company. The company digitizing biomarker analysis with the goal of advancing the science of precision health.
|
| IPO Date: |
December 7, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$182.3M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.77 | 3.38%
|
| Avg Daily Range (30 D): |
$0.20 | 6.27%
|
| Avg Daily Range (90 D): |
$0.17 | 4.74%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.34M |
| Avg Daily Volume (30 D): |
1.01M |
| Avg Daily Volume (90 D): |
1M |
| Trade Size |
| Avg Trade Size (Sh.): |
74 |
| Avg Trade Size (Sh.) (30 D): |
113 |
| Avg Trade Size (Sh.) (90 D): |
111 |
| Institutional Trades |
| Total Institutional Trades: |
1,306 |
| Avg Institutional Trade: |
$1.32M |
| Avg Institutional Trade (30 D): |
$1.55M |
| Avg Institutional Trade (90 D): |
$1.22M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.26M |
| Avg Closing Trade (30 D): |
$2.3M |
| Avg Closing Trade (90 D): |
$1.67M |
| Avg Closing Volume: |
49.78K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-2.34
|
$-.37
|
$-.47
|
|
Diluted EPS
|
$-2.34
|
$-.37
|
$-.47
|
|
Revenue
|
$144.98M
|
$36.42M
|
$43.86M
|
|
Gross Profit
|
$64.11M
|
$15.57M
|
$20.04M
|
|
Net Income / Loss
|
$-104.19M
|
$-17.54M
|
$-23.12M
|
|
Operating Income / Loss
|
$-140.54M
|
$-41.36M
|
$-24.75M
|
|
Cost of Revenue
|
$80.87M
|
$20.85M
|
$23.82M
|
|
Net Cash Flow
|
$-39.62M
|
$6.35M
|
$-8.45M
|
|
PE Ratio
|
|
|
|
|
|
|